Thursday, Feb 17:

Exhibits Open
10:00 AM – 9:45 PM EST

Novel Treatment Implementation: Prostate-Specific Membrane Antigen Targeting and Beyond
Primary Track: Prostate Cancer
10:45 AM – 12:30 PM EST

Optimizing Management of Localized Prostate Cancer: Artificial Intelligence, Active Surveillance, and Intervention
Primary Track: Prostate Cancer
1:00 PM – 2:30 PM EST

Trials in Progress Poster Session A: Prostate Cancer
Primary Track: Prostate Cancer- Advanced
2:30 PM – 4:00 PM EST

Poster Session A: Prostate Cancer
Primary Track: Prostate Cancer- Advanced
2:30 PM – 4:00 PM EST

Oral Abstract Session A: Prostate Cancer
Primary Track: Prostate Cancer- Advanced
4:00 PM – 5:30 PM EST

Evolution of Multidisciplinary Management Across the Spectrum of Prostate Cancer
Primary Track: Prostate Cancer
6:00 PM – 7:30 PM EST

Rapid Abstract Session A: Prostate Cancer
Primary Track: Prostate Cancer- Advanced
7:45 PM – 8:45 PM EST

Poster Session A (Continued) with Complimentary Wine and Cheese Reception
8:45 PM – 9:45 PM EST

Trials in Progress Poster Session A (Continued) with Complimentary Wine and Cheese Reception
8:45 PM – 9:45 PM EST

Poster Walks: Prostate Cancer
Primary Track: Prostate Cancer- Advanced
9:00 PM – 9:45 PM EST

 

Friday, Feb 18:

Rapid Abstract Session B: Urothelial Carcinoma
Primary Track: Urothelial Carcinoma
10:00 AM – 11:00 AM EST

Exhibits Open
10:00 AM – 9:15 PM EST

Novel Therapies and Their Toxicities in Bladder Cancer
Primary Track: Urothelial Carcinoma
11:15 AM – 12:30 PM EST

Keynote
Primary Track: Urothelial Carcinoma
1:00 PM – 1:45 PM EST

Potpourri of Hot Topics in Urothelial Carcinoma
Primary Track: Urothelial Carcinoma
2:00 PM – 3:30 PM EST

Trials in Progress Poster Session B: Urothelial Carcinoma
Primary Track: Urothelial Carcinoma
3:30 PM – 5:00 PM EST

Poster Session B: Urothelial Carcinoma
Primary Track: Urothelial Carcinoma
3:30 PM – 5:00 PM EST

Oral Abstract Session B: Urothelial Carcinoma
Primary Track: Urothelial Carcinoma
5:00 PM – 6:30 PM EST

Demystifying Next-Generation Sequencing in Urothelial Carcinoma: A Case-Based Approach
Primary Track: Urothelial Carcinoma
6:45 PM – 8:15 PM EST

Poster Session B (Continued) with Complimentary Wine and Cheese Reception
8:15 PM – 9:15 PM EST

Trials in Progress Poster Session B (Continued) with Complimentary Wine and Cheese Reception
8:15 PM – 9:15 PM EST

Poster Walks: Urothelial Carcinoma
Primary Track: Urothelial Carcinoma
8:30 PM – 9:15 PM EST

 

Saturday, Feb 19:

 

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Primary Track: Renal Cell Cancer
10:00 AM – 11:00 AM EST

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Primary Track: Renal Cell Cancer
10:00 AM – 11:00 AM EST

Regulating the Wild West: PET-Based Imaging in Trials and the Clinic
Primary Track: Prostate Cancer
10:00 AM – 11:00 AM EST

Rapid Abstract Session C: Renal Cell Cancer and Rare Tumors
Primary Track: Renal Cell Cancer
11:15 AM – 12:15 PM EST

Emerging Biomarkers and Therapies in Renal Cell Carcinoma
Primary Track: Renal Cell Cancer
12:45 PM – 2:15 PM EST

Management of Rare Variants in Genitourinary Cancers
Primary Track: Penile, Urethral, Testicular, and Adrenal Cancers
2:30 PM – 3:30 PM EST

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers (Continued) with Complimentary 3:30 PM – 5:00 PM EST

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers (Continued) with 3:30 PM – 5:00 PM EST

Poster Walks: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Primary Track: Adrenal Cancer
3:45 PM – 4:30 PM EST

Oral Abstract Session C: Renal Cell Cancer and Rare Tumors
Primary Track: Renal Cell Cancer
5:00 PM – 6:30 PM EST

From Genetic Testing to Systemic Therapies: Case-Based Panel on Renal Cell Carcinoma
Primary Track: Renal Cell Cancer
6:45 PM – 8:00 PM EST

Author